Literature DB >> 19692335

Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.

Heli Liu1, Ann H R Shim, Xiaolin He.   

Abstract

ADAMs (a disintegrin and metalloproteinases) are a family of multidomain transmembrane glycoproteins with diverse roles in physiology and diseases, with several members being drug targets for cancer and inflammation therapies. The spatial organization of the ADAM extracellular segment and its influence on the function of ADAMs have been unclear. Although most members of the ADAM family are active zinc metalloproteinases, 8 of 21 ADAMs lack functional metalloproteinase domains and are implicated in protein-protein interactions instead of membrane protein ectodomain shedding. One of such non-proteinase ADAMs, ADAM22, acts as a receptor on the surface of the postsynaptic neuron to regulate synaptic signal transmission. The crystal structure of the full ectodomain of mature human ADAM22 shows that it is a compact four-leaf clover with the metalloproteinase-like domain held in the concave face of a rigid module formed by the disintegrin, cysteine-rich, and epidermal growth factor-like domains. The loss of metalloproteinase activity is ensured by the absence of critical catalytic residues, the filling of the substrate groove, and the steric hindrance by the cysteine-rich domain. The structure, combined with calorimetric experiments, suggests distinct roles of three putative calcium ions bound to ADAM22, with one in the metalloproteinase-like domain being regulatory and two in the disintegrin domain being structural. The metalloproteinase-like domain contacts the rest of ADAM22 with discontinuous, hydrophilic, and poorly complemented interactions, suggesting the possibility of modular movement of ADAM22 and other ADAMs. The ADAM22 structure provides a framework for understanding how different ADAMs exert their adhesive function and shedding activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692335      PMCID: PMC2781453          DOI: 10.1074/jbc.M109.014258

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  The ADAM gene family: surface proteins with adhesion and protease activity.

Authors:  P Primakoff; D G Myles
Journal:  Trends Genet       Date:  2000-02       Impact factor: 11.639

2.  Intracellular processing of metalloprotease disintegrin ADAM12.

Authors:  Yi Cao; Qing Kang; Zhefeng Zhao; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2002-05-08       Impact factor: 5.157

Review 3.  The ADAMs family of proteins: from basic studies to potential clinical applications.

Authors:  Michael J Duffy; David J Lynn; Andrew T Lloyd; Caroline M O'Shea
Journal:  Thromb Haemost       Date:  2003-04       Impact factor: 5.249

4.  Regulation of human ADAM 12 protease by the prodomain. Evidence for a functional cysteine switch.

Authors:  F Loechel; M T Overgaard; C Oxvig; R Albrechtsen; U M Wewer
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

Review 5.  ADAMs: modulators of cell-cell and cell-matrix interactions.

Authors:  Judith M White
Journal:  Curr Opin Cell Biol       Date:  2003-10       Impact factor: 8.382

Review 6.  The ADAMs family of metalloproteases: multidomain proteins with multiple functions.

Authors:  Darren F Seals; Sara A Courtneidge
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

7.  Calcium dynamics in the extracellular space of mammalian neural tissue.

Authors:  D M Egelman; P R Montague
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

8.  Cloning and chromosomal mapping of mouse ADAM11, ADAM22 and ADAM23.

Authors:  K Sagane; K Yamazaki; Y Mizui; I Tanaka
Journal:  Gene       Date:  1999-08-05       Impact factor: 3.688

9.  Crystal structure of the catalytic domain of human ADAM33.

Authors:  Peter Orth; Paul Reichert; Wenyan Wang; Winifred W Prosise; Taisa Yarosh-Tomaine; Gerald Hammond; Richard N Ingram; Li Xiao; Urooj A Mirza; Jun Zou; Corey Strickland; S Shane Taremi; Hung V Le; Vincent Madison
Journal:  J Mol Biol       Date:  2004-01-02       Impact factor: 5.469

Review 10.  Structural aspects of the metzincin clan of metalloendopeptidases.

Authors:  F Xavier Gomis-Rüth
Journal:  Mol Biotechnol       Date:  2003-06       Impact factor: 2.695

View more
  22 in total

1.  Domain integration of ADAM family proteins: Emerging themes from structural studies.

Authors:  Tom Cm Seegar; Stephen C Blacklow
Journal:  Exp Biol Med (Maywood)       Date:  2019-07-23

2.  Evidence for restricted reactivity of ADAMDEC1 with protein substrates and endogenous inhibitors.

Authors:  Jacob Lund; Linda Troeberg; Henrik Kjeldal; Ole H Olsen; Hideaki Nagase; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

3.  Multiple non-catalytic ADAMs are novel integrin α4 ligands.

Authors:  Lei Wang; Jason A Hoggard; Erica D Korleski; Gideon V Long; Brandy C Ree; Kenneth Hensley; Stephen R Bond; Tyra G Wolfsberg; JianMing Chen; Tonya N Zeczycki; Lance C Bridges
Journal:  Mol Cell Biochem       Date:  2017-09-14       Impact factor: 3.396

4.  Monoclonal antibodies targeting the disintegrin-like domain of ADAMDEC1 modulates the proteolytic activity and enables quantification of ADAMDEC1 protein in human plasma.

Authors:  Jacob Lund; Anne Mette Elimar Bitsch; Morten Grønbech Rasch; Mari Enoksson; Linda Troeberg; Hideaki Nagase; Mette Loftager; Michael Toft Overgaard; Helle Heibroch Petersen
Journal:  MAbs       Date:  2017-11-29       Impact factor: 5.857

5.  Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10.

Authors:  Tom C M Seegar; Lauren B Killingsworth; Nayanendu Saha; Peter A Meyer; Dhabaleswar Patra; Brandon Zimmerman; Peter W Janes; Eric Rubinstein; Dimitar B Nikolov; Georgios Skiniotis; Andrew C Kruse; Stephen C Blacklow
Journal:  Cell       Date:  2017-12-07       Impact factor: 41.582

6.  N-glycosylation regulates ADAM8 processing and activation.

Authors:  Srimathi Srinivasan; Mathilde Romagnoli; Andrew Bohm; Gail E Sonenshein
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

7.  Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid.

Authors:  Susan A Austin; Zvonimir S Katusic
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-07       Impact factor: 6.200

Review 8.  The LGI1 protein: molecular structure, physiological functions and disruption-related seizures.

Authors:  Paul Baudin; Louis Cousyn; Vincent Navarro
Journal:  Cell Mol Life Sci       Date:  2021-12-30       Impact factor: 9.261

9.  Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage.

Authors:  Rielana Wichert; Franka Scharfenberg; Cynthia Colmorgen; Tomas Koudelka; Jeanette Schwarz; Sebastian Wetzel; Barbara Potempa; Jan Potempa; Jörg W Bartsch; Irit Sagi; Andreas Tholey; Paul Saftig; Stefan Rose-John; Christoph Becker-Pauly
Journal:  FASEB J       Date:  2019-08-09       Impact factor: 5.191

10.  Cross-domain inhibition of TACE ectodomain.

Authors:  Christopher J Tape; Sofie H Willems; Sarah L Dombernowsky; Peter L Stanley; Marton Fogarasi; Willem Ouwehand; John McCafferty; Gillian Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.